CITURGIA
Citurgia Biochemicals share price & financials
- Price
- ₹119.85
- Market cap
- ₹1.3k Cr
Quarterly results
Q1 FY27: net profit up 0.0% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | -0 | -0 | -0 | -0 | -0 +38% | -0 −360% | -0 −233% | -0 +0% |
| Net profit | -0 | -0 | -0 | -0 | -0 +21% | -0 −190% | -0 −117% | -0 +0% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance +114.1% YTD
YTD: ₹49.77 on 10 Feb 2026 → ₹106.55. High ₹203.35 (24 Mar 2026), low ₹49.77 (10 Feb 2026).
Financials, as filed
| Year ending | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Operating profit | ₹-0 Cr | ₹-0 Cr | ₹-1 Cr |
| Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Depreciation | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net profit | ₹-0 Cr | ₹-0 Cr | ₹-1 Cr |
| Cash from operations | ₹-0 Cr | ₹-0 Cr | ₹-0 Cr |
| Free cash flow | ₹-0 Cr | ₹-0 Cr | ₹-0 Cr |
| ROCE | -145.4% | -2150.0% | — |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹26 Cr | ₹26 Cr | ₹26 Cr | ₹26 Cr | ₹26 Cr | ₹26 Cr |
| Reserves | ₹-32 Cr | ₹-32 Cr | ₹-33 Cr | ₹-33 Cr | ₹-34 Cr | ₹-34 Cr |
| Borrowings | ₹6 Cr | ₹6 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr |
| Other liabilities | ₹10 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr |
| Total liabilities | ₹12 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹10 Cr | ₹10 Cr |
| Fixed assets | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr |
| Capital work in progress | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other assets | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr |
| Total assets | ₹12 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹10 Cr | ₹10 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
The ownership split has held steady since Jun 2025. The shareholder count grew 7% to 5,762.
- Promoters
- 99.4%
- Public
- 0.6%
Since Jun 2025
- Public −0.01 pp
- Promoters 0.00 pp
How it drifted, 12 quarters
Ownership split by quarter, oldest first. Sep '23: Promoters 99.7%, Public 0.3%.Dec '23: Promoters 99.7%, Public 0.3%.Mar '24: Promoters 99.7%, Public 0.3%.Jun '24: Promoters 99.7%, Public 0.3%.Sep '24: Promoters 99.7%, Public 0.3%.Dec '24: Promoters 99.7%, Public 0.3%.Mar '25: Promoters 99.7%, Public 0.3%.Jun '25: Promoters 99.4%, Public 0.6%.Sep '25: Promoters 99.4%, Public 0.6%.Dec '25: Promoters 99.4%, Public 0.6%.Mar '26: Promoters 99.4%, Public 0.6%.Jun '26: Promoters 99.4%, Public 0.6%.
Who is on the register
Named in the Jun 2026 filing
Every holder of Citurgia Biochemicals Ltd above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Satya Sheel Engineers And Miners Private Limited | 60.64% | unchanged |
| Dev Versha Jetro Valley Private Limited | 27.14% | unchanged |
| Gandharva Holding Limited | 5.79% | unchanged |
| Gem Info Solutions Private Limited | 5.75% | unchanged |
| Elite Capital & Management Services Limited | 0.04% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse Citurgia Biochemicals Ltd
Guides on how to read this kind of business and the numbers that matter.